Literature DB >> 27802818

Retraction note: Decrease expression and clinicopathological significance of miR-148a with poor survival in hepatocellular carcinoma tissues.

Hossein Ajdarkosh1, Masoomeh Dadpay2, Emad Yahaghi3, Elham Rostami Pirzaman4, Amir Farshid Fayyaz5, Ebrahim Khodaverdi Darian6, Aram Mokarizadeh7.   

Abstract

Entities:  

Year:  2016        PMID: 27802818      PMCID: PMC5090897          DOI: 10.1186/s13000-016-0561-8

Source DB:  PubMed          Journal:  Diagn Pathol        ISSN: 1746-1596            Impact factor:   2.644


× No keyword cloud information.

Retraction

The Editor-in-Chief and Publisher have retracted this article [1] because the scientific integrity of the content cannot be guaranteed. An investigation by the Publisher found it to be one of a group of articles we have identified as showing evidence suggestive of attempts to subvert the peer review and publication system to inappropriately obtain or allocate authorship. This article showed evidence of plagiarism (most notably from the articles cited [2, 3]) and authorship manipulation.
  3 in total

1.  microRNA-148a inhibits hepatocellular carcinoma cell invasion by targeting sphingosine-1-phosphate receptor 1.

Authors:  Shu-Liang Zhang; Ling Liu
Journal:  Exp Ther Med       Date:  2014-12-16       Impact factor: 2.447

2.  MiR-148b suppresses cell proliferation and invasion in hepatocellular carcinoma by targeting WNT1/β-catenin pathway.

Authors:  Jun-gang Zhang; Ying Shi; De-fei Hong; Mengqi Song; Dongsheng Huang; Chun-you Wang; Gang Zhao
Journal:  Sci Rep       Date:  2015-01-28       Impact factor: 4.379

3.  Decrease expression and clinicopathological significance of miR-148a with poor survival in hepatocellular carcinoma tissues.

Authors:  Hossein Ajdarkosh; Masoomeh Dadpay; Emad Yahaghi; Elham Rostami Pirzaman; Amir Farshid Fayyaz; Ebrahim Khodaverdi Darian; Aram Mokarizadeh
Journal:  Diagn Pathol       Date:  2015-08-07       Impact factor: 2.644

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.